Clinical Trial

Study of CU06-1004 in Patients With Daibetic Macular Edema

Name: Study of CU06-1004 in Patients With Daibetic Macular Edema — clinical trial record (NCT07459829)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This phase 2b trial is a randomized, double-masked, parallel-group, multi-center study in approximately 156 patients with DME to evaluate the efficacy and safety of CU06-1004 orally administered once daily for 24 weeks. The study will have a 1:1:1 randomization (CU06-1004 200mg: CU06-1004 300mg: Placebo).

Trial Details

NCT Number	NCT07459829
Lead Sponsor	Curacle Co., Ltd.
Conditions	DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)
Enrollment	156 participants
Start Date	2026-12-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2028-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-10